Clinical Trial Update: Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors [NA]

View source ↗

Summary

Clinical trial evaluating perioperative dexmedetomidine for preventing postoperative delirium in patients with brain tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Postoperative Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Postoperative Delirium | NA | Status: RECRUITING